LSOMS Holdings Completes First Acquisition, Strengthening Compliance & Lab Validation Service Offerings for Life Sciences Firms

3 Boomerang Portfolio Company Acquires Pinnaql as First Step to Scale Best-in-Class Consulting Platform for Guiding Clients Through Complex Regulatory Environments

FISHERS, Ind. and MALVERN, Pa., June 17, 2025 /PRNewswire/ -- LSOMS Holdings, L.P. ("LSOMS" or the "Company"), a 3 Boomerang Capital, LP ("3BC") portfolio company, today announced it acquired Pinnaql, Inc. ("Pinnaql"), a provider of laboratory validation and global GxP compliance services. The majority investment marks the first acquisition of LSOMS. The Company was recently launched by 3BC to build a leading quality and regulatory consulting platform dedicated to helping life–science innovators navigate increasingly complex compliance landscapes. LSOMS will leverage the Pinnaql brand to build a market-leading platform in the life sciences consulting space.

Founded in 2019, Malvern, Pennsylvania-based Pinnaql partners with pharmaceutical, biotech, and medical device companies to deliver tailored solutions that ensure regulatory and operational readiness in laboratory environments. The Pinnaql team's expertise in quality standards and complex lab instrument validation enables clients to meet stringent regulatory requirements across highly regulated end markets, particularly in the biopharmaceutical space.

"Pinnaql's focus on technical excellence and exceptional client service fits seamlessly with the values that drove us to build the initial platform," said John Duffin, Chief Executive Officer of LSOMS Holdings. "By partnering with Pinnaql, we gain immediate scale in laboratory instrument lifecycle management and validation with leading pharmaceutical companies that our experts have served for years. This acquisition complements our existing engineering and consulting services, enabling us to better support clients through the complex drug and medical device product lifecycles."

The Pinnaql acquisition deepens LSOMS's core offerings in compliance and validation—critical domains for life sciences organizations—and represents the first step in a broader strategy to scale its best-in-class platform.

"3BC is excited about adding Pinnaql to the LSOMS platform, and believes that the acquisition will elevate LSOMS's compliance function and broaden the team's validation services talent pool within high-growth end markets," said Peter Wen, Principal at 3 Boomerang Capital. "We continue to seek out partners to strengthen our offering for life sciences companies."

About Pinnaql, Inc.

LSOMS Holdings (DBA Pinnaql) provides quality, regulatory, and operational excellence consulting to biopharmaceutical, medical device, and CDMO companies worldwide. The company's mission is to deliver expert-driven, compliant solutions that empower clients to accelerate innovation and improve human health. Pinnaql supports life sciences organizations by ensuring operational readiness, reducing the risk of regulatory setbacks, and enabling clients to stay focused on advancing science, supporting patients, and bringing new therapies to market. As a trusted partner, Pinnaql elevates compliance and empowers innovation across the product lifecycle.

For more information, visit https://www.pinnaql.co

About 3 Boomerang Capital

3 Boomerang Capital is a lower-middle-market healthcare private equity firm committed to fostering creative investment partnerships with healthcare entrepreneurs across North America and Western Europe. 3BC's areas of investment focus span four key healthcare sectors: Biopharma outsourcing, medical device and diagnostic manufacturing, information technology and tech-enabled services, and alternate site care. The firm specializes in backing founder-led businesses, providing the guidance and resources needed for successful growth and innovation in the healthcare market. By strategically concentrating on four core areas, 3 Boomerang Capital is well-equipped to deliver on its mission of empowering healthcare entrepreneurs and propelling healthcare businesses to new heights. The firm is currently investing out of its flagship fund, 3 Boomerang Capital I, LP, a $376 million investment vehicle.

For more information, visit https://www.3boomerang.com/

Media Contact
Laura Simpson
JConnelly for 3 Boomerang Capital
[email protected]

SOURCE 3 Boomerang Capital